1Chowers,-Y; Cahalon,-L; Lahav,-M; et al. Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL8 and IL-1 beta secretion from intestinal epithelial cells. J Immunol, 2000,165(6): 2955-2961.
2Payer J, Huorka M, Duris I, et al. Plasma somatostatin levels in ulcerativecolitis. Hepatogastroenterology, 1994,41(6): 552-553.
3Koch TR, Carney JA, Morris VA, et al. Somatostatin in the idiopathic inflammatory bowel disease. Dis Colon Rectum, 1988,31(3): 198-203.
4Watanabe T, Kubota Y, Sawada T,et al. Distribution and quantification of somatostatin in inflammatory disease. Dis Co lon Rectum, 1992, 35 (5):488-494.
5Eliakim R, Karmeli F, Rachmilewitz D. Decreased somatostatin (SS) generation by colonic mucosa in active ulcerative colitis. Gastro enterology,1991, 100(4Pt2): A578.
6Lamrani A, Tulliez M, Chauvelot-Moachon L, et al. Effects of octreotide treatment on early TNF-alpha production and localization in experimental chronic colitis. Aliment Pharmacol Ther, 1999,13(5): 583-594.
7van-Bergeijk,Van Meaneteren ME,Tak C J,et al. Somatostatin does not attenuate intestinal injury in dextran sodium sulphate-induced subacute colitis. Mediators Inflamm, 1998,7(3): 169-173.
8van-Bergeijk,J D, Wilson-J-H, Nielsen, et al. Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids. Eur J Gastroenterol Hepatol,2002,14(3): 243-248.
2Dr. J. M. Lundberg,A. ?ngg?rd,J. Pernow,T. H?kfelt. Neuropeptide Y-, substance P- and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control[J] 1985,Cell and Tissue Research(1):9～18
3John Foreman,Chris Jordan. Histamine release and vascular changes induced by neuropeptides[J] 1983,Agents and Actions(2-3):105～116
